17:01 EDT Enliven (ELVN) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELVN:
- Enliven reports Q2 EPS (49c) vs. (41c) last year
- Enliven Therapeutics’ Promising Phase 1a/1b Study on ELVN-002 in HER2+ Cancers
- Enliven Therapeutics’ Promising CML Treatment: A Study Update
- Enliven Therapeutics’ Promising CML Study Update: What Investors Need to Know
- Enliven Therapeutics Advances CML Treatment with ELVN-001 Study